Roche’s Analyst Event at ASCO 2019
Roche has hosted an analyst briefing to discuss data presented on the Roche Group’s oncology products and pipeline at the American Society of Clinical Oncology Annual Meeting (ASCO) in Chicago (1 – 5 June 2018).
| Agenda | |
|---|---|
| Welcome | Karl Mahler, Head of Investor Relations |
| ASCO 2019 Key readouts across tumor types | Hematology Nancy Valente, M.D., Global Head of Product Development - Hematology Breast cancer, lung cancer & pan-tumor Alan Sandler, M.D., Global Head of Product Development - Solid Tumors |
| Roche Oncology strategy update | Bill Anderson, CEO Roche Pharmaceuticals |
| Q&A | |
Please register to access the replay* *Privacy notice
Investors